JAK inhibitor Oclacitinib maleate, Purity ≥98%

Cat. No.: X23-10-ZQ404

JAK inhibitor Oclacitinib maleate, Purity ≥98%

Synonym: OCLACITINIB MALEATE; 1208319-27-0; 1640292-55-2; Oclacitinib (maleate); Apoquel; Oclacitinib maleate [USAN]; Oclacitinib Maleate(PF-03394197); JAK inhibitor

  • CAS Number: 1640292-55-2
  • Compound CID: 44631937
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Oclacitinib maleate, soluble in DMSO, water and ethanol, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, and Tyk2.
Molecular Weight
453.51
Molecular Formula
C19H27N5O6S
Targets
JAK1: 10 nM; JAK2: 18 nM; JAK3: 99 nM; Tyk2: 84 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 81 mg/mL (178.61 mM); Water: 16 mg/mL (35.28 mM); Ethanol: 81 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Oclacitinib maleate can be researched for the inhibition of JAK1 pathways in various models.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.